Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1α
- 1 July 2005
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (1), 173-179
- https://doi.org/10.1016/j.jtcvs.2004.11.044
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Skeletal myoblast transplantation for cardiac repairExpert Review of Cardiovascular Therapy, 2004
- Cell transplantation to prevent heart failure: a comparison of cell typesThe Annals of Thoracic Surgery, 2003
- Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell, 2003
- Physiological Coupling of Donor and Host Cardiomyocytes After Cellular TransplantationCirculation Research, 2003
- Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effectsThe Annals of Thoracic Surgery, 2002
- Transplantation of embryonic stem cells improves cardiac function in postinfarcted ratsJournal of Applied Physiology, 2002
- Factors affecting functional outcome after autologous skeletal myoblast transplantationThe Annals of Thoracic Surgery, 2001
- Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular functionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998
- Skeletal myoblast transplantation for repair of myocardial necrosis.Journal of Clinical Investigation, 1996